Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Early research (Phase 1)Study completedNCT03121716
What this trial is testing

Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 23
Testing effectiveness (Phase 2)Ended earlyNCT00025298
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerOral Complications+1 more
European Organisation for Research and Treatment of Cancer - EORTC 5
Not applicableLooking for participantsNCT06463392
What this trial is testing

Deep Learning-based sbORN Diagnostic Model

Who this might be right for
Nasopharyngeal CarcinomaHerpesvirus 4, Human
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 312
Testing effectiveness (Phase 2)UnknownNCT01735409
What this trial is testing

Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 69
Post-approval studies (Phase 4)Study completedNCT00772681
What this trial is testing

Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma

Who this might be right for
Head and Neck Neoplasms
Sanofi 57
Early research (Phase 1)Study completedNCT00609219
What this trial is testing

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC

Who this might be right for
Head and Neck Cancer
Baylor College of Medicine 25
Not applicableLooking for participantsNCT07019870
What this trial is testing

Screening for Early Diagnosis of Nose Cancer

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 20,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374
What this trial is testing

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 490
Not applicableStudy completedNCT00388024
What this trial is testing

PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
Wake Forest University Health Sciences 19
Large-scale testing (Phase 3)Study completedNCT00101582
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
MucositisSolid TumorsStomatitis+2 more
Swedish Orphan Biovitrum 188
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07555860
What this trial is testing

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Early research (Phase 1)WithdrawnNCT00181220
What this trial is testing

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Johns Hopkins University
Testing effectiveness (Phase 2)Study completedNCT00114283
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+31 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT03003182
What this trial is testing

Nasopharyngeal Carcinoma From Guangdong

Who this might be right for
Nasopharyngeal Cancer
Sun Yat-sen University 2,000
Testing effectiveness (Phase 2)Study completedNCT01449942
What this trial is testing

Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiangya Hospital of Central South University 40
Not applicableEnded earlyNCT00393224
What this trial is testing

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Who this might be right for
Nasopharyngeal Neoplasms
National Cancer Institute (NCI) 952
Early research (Phase 1)Study completedNCT01847326
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+8 more
University of Chicago 48
Testing effectiveness (Phase 2)UnknownNCT03925090
What this trial is testing

Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 150
Early research (Phase 1)Study completedNCT00516087
What this trial is testing

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

Who this might be right for
Nasopharyngeal Carcinoma
Baylor College of Medicine 23
Next Page